Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA pac-1 GDSC1000 pan-cancer AAC 0.067 0.06
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.063 0.06
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.063 0.06
mRNA Epothilone B FIMM pan-cancer AAC -0.3 0.06
mRNA Sorafenib CCLE pan-cancer AAC 0.089 0.07
mRNA CID-5951923 CTRPv2 pan-cancer AAC -0.068 0.07
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.07
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.088 0.07
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.056 0.07
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.08
Download CSV